Barzolvolimab

Tax included
Barzolvolimab (CDX 0159) is a humanized anti-KIT IgG1 monoclonal antibody. Barzolvolimab specificity and potently inhibits KIT activation by SCF. Barzolvolimab can reduce skin mast cells and disease activity in chronic inducible urticaria.
MedChemExpress 
HY-P99462

Data sheet

Size
Multiple sizes
Reactivity
c-Kit
CAS
2438203-51-9